141 related articles for article (PubMed ID: 35238443)
1. Risk of diabetes in haemophilia patients compared to clinic and non-clinic control cohorts.
Pandey B; Barnes RFW; Sun HL; Jackson S; Kruse-Jarres R; Quon DV; von Drygalski A
Haemophilia; 2022 May; 28(3):445-452. PubMed ID: 35238443
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population.
Barnes RFW; Pandey B; Sun HL; Jackson S; Kruse-Jarres R; Quon DV; von Drygalski A
Haemophilia; 2022 Nov; 28(6):e228-e236. PubMed ID: 35877992
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
Ter-Zakarian A; Barnes RFW; Kruse-Jarres R; Quon DV; Jackson S; Sun HL; von Drygalski A
Haemophilia; 2022 Nov; 28(6):977-985. PubMed ID: 35768896
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States.
Sait AS; Kuo A; Bettencourt R; Bergstrom J; Allison M; von Drygalski A
Haemophilia; 2014 Nov; 20(6):763-70. PubMed ID: 24893625
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.
Husseinzadeh H; Chiasakul T; Gimotty PA; Pukenas B; Wolf R; Kelty M; Chiang E; Fogarty PF; Cuker A
Haemophilia; 2018 Mar; 24(2):271-277. PubMed ID: 29282815
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for hypertension in hemophilia.
von Drygalski A; Kolaitis NA; Bettencourt R; Bergstrom J; Kruse-Jarres R; Quon DV; Wassel C; Li MC; Waalen J; Elias DJ; Mosnier LO; Allison M
Hypertension; 2013 Jul; 62(1):209-15. PubMed ID: 23630949
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
Sharathkumar AA; Soucie JM; Trawinski B; Greist A; Shapiro AD
Haemophilia; 2011 Jul; 17(4):597-604. PubMed ID: 21323799
[TBL] [Abstract][Full Text] [Related]
8. Renal disease among males with haemophilia.
Kulkarni R; Soucie JM; Evatt B;
Haemophilia; 2003 Nov; 9(6):703-10. PubMed ID: 14750936
[TBL] [Abstract][Full Text] [Related]
9. Management of comorbidities in haemophilia.
Kempton CL; Makris M; Holme PA
Haemophilia; 2021 Feb; 27 Suppl 3():37-45. PubMed ID: 32476243
[TBL] [Abstract][Full Text] [Related]
10. The ageing patient with haemophilia.
Canaro M; Goranova-Marinova V; Berntorp E
Eur J Haematol; 2015 Feb; 94 Suppl 77():17-22. PubMed ID: 25560790
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia.
Yıldız M; Özdemir N; Önal H; Koç B; Eliuz Tipici B; Zülfikar B
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):173-180. PubMed ID: 30582317
[TBL] [Abstract][Full Text] [Related]
12. Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.
Nagao A; Suzuki N; Takedani H; Yamasaki N; Chikasawa Y; Sawada A; Kanematsu T; Nojima M; Higasa S; Amano K; Fukutake K; Fujii T; Matsushita T; Suzuki T
Haemophilia; 2019 Jul; 25(4):e223-e230. PubMed ID: 31045306
[TBL] [Abstract][Full Text] [Related]
13. How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population.
Berger K; Schopohl D; Lowe G; Holme PA; Tait RC; Combescure C; Rauchensteiner S; Klamroth R
Haemophilia; 2016 Sep; 22(5):e406-16. PubMed ID: 27650262
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factors among adult patients with haemophilia.
Camelo RM; Caram-Deelder C; Duarte BP; de Moura MCB; Costa NCM; Costa IM; Roncal CGP; Vanderlei AM; Guimaraes TMR; Gouw S; Rezende SM; van der Bom J
Int J Hematol; 2021 Jun; 113(6):884-892. PubMed ID: 33677769
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease (CVD) in Canadians with haemophilia: Age-Related CVD in Haemophilia Epidemiological Research (ARCHER study).
Minuk L; Jackson S; Iorio A; Poon MC; Dilworth E; Brose K; Card R; Rizwan I; Chin-Yee B; Louzada M
Haemophilia; 2015 Nov; 21(6):736-41. PubMed ID: 26222883
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe.
Schutgens RE; Klamroth R; Pabinger I; Malerba M; Dolan G;
Haemophilia; 2014 Sep; 20(5):682-6. PubMed ID: 24724839
[TBL] [Abstract][Full Text] [Related]
17. Haemophilia Experiences, Results and Opportunities (HERO study) in Brazil: Assessment of the psychosocial effects of haemophilia in patients and caregivers.
Lorenzato CS; Santos RB; Fagundes GZZ; Ozelo MC
Haemophilia; 2019 Jul; 25(4):640-650. PubMed ID: 31115094
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors associated with hepatitis C among Brazilian male patients with haemophilia: A long-term follow-up.
Carmo RA; Martins ML; Chaves DG; Dezanet LNC
Haemophilia; 2019 May; 25(3):447-455. PubMed ID: 30866172
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease prevalence and relevance in haemophilia: a scoping review.
Rizwan I; Minuk L; Jackson S; Iorio A
Haemophilia; 2015 May; 21(3):e156-e166. PubMed ID: 25420604
[TBL] [Abstract][Full Text] [Related]
20. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters.
Tuinenburg A; Biere-Rafi S; Peters M; Verhamme P; Peerlinck K; Kruip MJ; Laros-Van Gorkom BA; Roest M; Meijers JC; Kamphuisen PW; Schutgens RE
Haemophilia; 2013 Sep; 19(5):744-52. PubMed ID: 23659471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
